Gå til indhold
FORSIDEN | PRINT | SITEMAP |
Header

List of Publications

Danish Colorectal Cancer Center South

Publications List 2021

Andre T, Amonkar M, Norquist JM, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Sevilla I, De La Fouchardiere C, Rivera F, Elez E, Diaz LA Jr, Yoshino T, Van Cutsem E, Yang P, Farooqui M, Le DT. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial. Lancet Oncol. 2021 Apr 1:S1470-2045(21)00064-4. doi: 10.1016/S1470-2045(21)00064-4. PMID: 33812497
  

Faaborg PM, Haas S, Liao D, Ploen J, Jakobsen A, Rahr HB, Laurberg S, Gregersen H, Lundby L, Christensen P, Krogh K. Long-term anorectal function in rectal cancer patients treated with chemoradiotherapy and endorectal brachytherapy. Colorectal Dis. 2021 doi: 10.1111/codi.15692, PMID 33900676
 

Gregersen TA, Birkelund R, Wolderslund M, Steffensen KD, Ammentorp J. When life gives you no choice: Context of decision-making when offered an oncology clinical trial. Caring Sci. 2021 doi: 10.1111/scs.12965. PMID: 33606286
 

Hamre TR, Stougaard JK, Havelund BM, Jensen LH, Hansen TF. Re-exposure to immunotherapy in metastatic colon cancer: A case report. Clin Case Rep. 2021 24;9(6):e04349. doi: 10.1002/ccr3.4349. PMID: 34194811
 

Hansen DG, Trabjerg TB, Sisler JJ, Søndergaard J, Jensen LH. Cross-sectoral communication by bringing together patient with cancer, general practitioner and oncologist in a video-based consultation: a qualitative study of oncologists' and nurse specialists' perspectives. BMJ Open. 2021 5;11(5):e043038. doi: 10.1136/bmjopen-2020-043038. PMID: 33952540
 

Hansen TF, Qvortrup C, Pfeiffer P. Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data. Cancers (Basel). 2021 13:1031. doi: 10.3390/cancers13051031. PMID: 33804554
 

Jakobsen A, Andersen RF, Hansen TF, Jensen LH, Faaborg L, Steffensen KD, Thomsen CB, Wen SWC. Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival. Eur J Cancer. 2021 149:128-133. doi: 10.1016/j.ejca.2021.03.006. PMID: 33857886
 

Klein MF, Seiersen M, Bulut O, Bech-Knudsen F, Jansen JE, Gögenur I. Short-term outcomes after transanal total mesorectal excision for rectal cancer in Denmark - a prospective multicentre study.
Colorectal Dis. 2021 23(4):834-842. doi: 10.1111/codi.15454. PMID: 33226722
 

Loft MK, Pedersen MRV, Rahr HB, Rafaelsen SR. Can Ultrasound Elastography Discriminate between Rectal Adenoma and Cancer? A Systematic Review. Cancers (Basel). 2021 18;13:4158. doi: 10.3390/cancers13164158. PMID: 34439313


Nottelmann L, Groenvold M, Vejlgaard TB, Petersen MA, Jensen LH. Early, integrated palliative rehabilitation improves quality of life of patients with newly diagnosed advanced cancer: The Pal-Rehab randomized controlled trial. Palliat Med. 2021 35(7):1344-1355. doi: 10.1177/02692163211015574. PMID: 34000886
 

Rattenborg S, Bundgaard L, Andersen J, Lindebjerg J, Kuhn J, Jakobsen CJ, Rahr HB. Intracorporeal annastomosis in right hemicolectomy for colon cancer: short-term outcomes with the DaVinci Xi robot. J Robot Surg. 2021 doi: 10.1007/s11701-020-01188-y. .PMID: 33492567
 

Silva CMS, Barros-Filho MC, Wong DVT, Mello JBH, Nobre LMS, Wanderley CWS, Lucetti LT, Muniz HA, Paiva IKD, Kuasne H, Ferreira DPP, Cunha MPSS, Hirth CG, Silva PGB, Sant'Ana RO, Souza MHLP, Quetz JS, Rogatto SR, Lima-Junior RCP. Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer. Cancers (Basel). 2021 13:1493. doi: 10.3390/cancers13071493. PMID: 33804927
 

Smit MA, van Pelt GW, Dequeker EM, Al Dieri R, Tollenaar RA, van Krieken JHJ, Mesker WE; UNITED Group e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study.
JMIR Form Res. 2021 19;5:e19408. doi: 10.2196/19408. PMID: 3373929
 

Therkildsen C, Jensen LH, Rasmussen M, Bernstein I. An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome. Clin Exp Gastroenterol. 2021 24;14:181-197. doi: 10.2147/CEG.S278054. PMID: 34079322
 

Trabjerg TB, Jensen LH, Sondergaard J, Wehberg S, Sisler JJ, Hansen DG. Cross-sectoral video consultation in cancer care: GPs' evaluation of a randomised controlled trial. BJGP Open. 2021 Feb 16:BJGPO.2020.0114. doi: 10.3399/BJGPO.2020.0114. PMID: 33293407

 

 

 

2020


Frostberg E, Pedersen MR, Manhoobi Y, Rahr HB, Rafaelsen SR. Three different computed tomography obesity indices, two standard methods, and one novel measurement, and their association with outcomes after colorectal cancer surgery. Acta Radiol. 2020 26:284185120918373. doi: 10.1177/0284185120918373. PMID: 32338034


Halligan S, Tolan D, Amitai MM, Hoeffel C, Kim SH, Maccioni F, Morrin MM, Mortele KJ, Rafaelsen SR, Rimola J, Schmidt S, Stoker J, Yang J. ESGAR consensus statement on the imaging of fistula-in-ano and other causes of anal sepsis. Eur Radiol. 2020 30:4734-4740. doi: 10.1007/s00330-020-06826-5. PMID: 32307564


Thomsen CB, Jakobsen A. Circulating tumor-specific DNA: a stony road to clinical utility. Biomark Med. 2020 14:331-333. doi: 10.2217/bmm-2019-0552. PMID: 32250154


Trabjerg TB, Jensen LH, Søndergaard J, Sisler JJ, Hansen DG. Cross-sectoral video consultations in cancer care: perspectives of cancer patients, oncologists and general practitioners. Support Care Cancer. 2020 doi: 10.1007/s00520-020-05467-0. PMID: 32318872


Erbs E, Rafaelsen SR, Lindebjerg J, Jensen LH, Hansen TF. The impact of mismatch repair status to the preoperative staging of colon cancer: implications for clinical management. Colorect. Cancer. 2020 doi: 10.2217/crc-2020-0001 eISSN 1758-1958


Matsuyama T, Kandimalla R, Ishikawa T, Takahashi N, Yamada Y, Yasuno M, Kinugasa Y, Hansen TF, Fakih M, Uetake H, Győrffy B, Goel A. A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer. Int J Cancer. 2020 doi: 10.1002/ijc.33129. PMID: 32657428


Thomsen CB, Hansen TF, Andersen RF, Lindebjerg J, Jensen LH, Jakobsen A. Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer. Ther Adv Med Oncol. 2020 doi: 10.1177/1758835920918472. PMID: 32518596


Bjerrum A, Lindebjerg J, Andersen O, Fischer A, Lynge E. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort. Int J Cancer. 2020 doi: 10.1002/ijc.32850. PMID: 31894860
 

Pedersen MRV, Dam C, Loft M, Rafaelsen SR. Reporting colon cancer staging using a template. Eur J Radiol Open. 2020 7: 100213. doi: 10.1016/j.ejro.2020.01.002. PMID: 32021880
 

Lyhne JD, Smith A'B, Frostholm L, Fink P, Jensen LH. Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survivors. BMC Cancer. 2020 20:223. doi: 10.1186/s12885-020-06731-6. PMID: 32178640
 

Trabjerg TB, Jensen LH, Sondergaard J, Trabjerg ND, Sisler JJ, Hansen DG. Investigating whether shared video-based consultations with patients, oncologists, and GPs can benefit patient-centred cancer care: a qualitative study. BJGP Open. 2020 doi: 10.3399/bjgpopen20X101023. PMID: 32238390
 

Frostberg E, Rahr HB. Clinical characteristics and a rising incidence of early-onset colorectal cancer in a nationwide cohort of 521 patients aged 18-40 years. Cancer Epidemiol. 2020 66:101704. doi: 10.1016/j.canep.2020.101704. PMID: 32234586
 

Coscia F, Doll S, Bech JM, Schweizer L, Mund A, Lengyel E, Lindebjerg J, Madsen GI, Moreira JMA, Mann M. A streamlined mass spectrometry-based proteomics workflow for large scale FFPE tissue analysis. J Pathol. 2020 doi: 10.1002/path.5420. PMID: 32154592
 

Pedersen MRV, Dam C, Rafaelsen SR. Music and pain during endorectal ultrasonography examination: A prospective questionnaire study and literature review. Radiography (Lond). 2020 doi: 10.1016/j.radi.2020.01.004. PMID: 3205274

 

2019


Nottelmann L, Jensen LH, Vejlgaard TB, Groenvold M. A new model of early, integrated palliative care: palliative rehabilitation for newly diagnosed patients with non-resectable cancer. Support Care Cancer. 2019 doi: 10.1007/s00520-018-4629-8.
 

Nuernberg D, Saftoiu A, Barreiros AP, Burmester E, Ivan ET, Clevert DA, Dietrich CF, Gilja OH, Lorentzen T, Maconi G, Mihmanli I, Nolsoe CP, Pfeffer F, Rafaelsen SR, Sparchez Z, Vilmann P, Waage JER. EFSUMB Recommendations for Gastrointestinal Ultrasound Part 3: Endorectal, Endoanal and Perineal Ultrasound. Ultrasound Int Open. 2019 Jan;5:E34-E51. doi: 10.1055/a-0825-6708.
 

Eriksen AC, Sørensen FB, Lindebjerg J, Hager H, dePont Christensen R, Kjær-Frifeldt S, Hansen TF. Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide population based cohort. BMC Cancer. 2019 12;19:142. doi: 10.1186/s12885-019-5345-6
 

Thomsen CB, Andersen RF, Lindebjerg J, Hansen TF, Jensen LH, Jakobsen A. Correlation between tumor-specific mutated and methylated DNA in colorectal cancer. JCO Precision Oncology. 2019 doi: 10.1200/PO.18.00162
 

Hansen TF, Nederby L, Zedan AH, Mejlholm I, Henriksen JR, Steffensen KD, Thomsen CB, Raunkilde L, Jensen LH, Jakobsen A. Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer. Transl Oncol. 2019 12:968-972. doi: 10.1016/j.tranon.2019.04.002.
 

Trabjerg ND, Rask C, Jensen LH, Hansen TF. Pseudoprogression during treatment with pembrolizumab followed by rechallenge with chemotherapy in metastatic colorectal cancer: A case report. Clin Case Rep. 2019 18:1445-1449. doi: 10.1002/ccr3.2262.
 

Trabjerg TB, Jensen LH, Søndergaard J, Sisler JJ, Hansen DG. Improving continuity by bringing the cancer patient, general practitioner and oncologist together in a shared video-based consultation - protocol for a randomised controlled trial. BMC Fam Pract. 2019 20:86. doi: 10.1186/s12875-019-0978-8.
 

Frostberg E, Christensen RD, Rahr HB. The day of week of elective colorectal cancer surgery has no impact on mortality and morbidity. Dan Med J. 2019 66. pii: A5550.
 

Ellebaek MB, Rahr HB, Boye S, Fristrup C, Qvist N. Detection of early anastomotic leakage by intraperitoneal microdialysis after low anterior resection for rectal cancer: a prospective cohort study. Colorectal Dis. 2019 18. doi: 10.1111/codi.14781.
 

Rahr HB, Streym S, Kryh-Jensen CG, Hougaard HT, Knudsen AS, Kristensen SH, Ejlersen E. Screening and systematic follow-up for cardiopulmonary comorbidity in elective surgery for colorectal cancer: a randomised feasibility study. World J Surg Oncol. 2019 17:127. doi: 10.1186/s12957-019-1668-7.
 

Pedersen MRV, Dam C, Rafaelsen SR. Perforated adenocarcinoma of the colon within a scrotal hernia imaged by CT: case report and literature review. Radiol Case Rep. 2019 14:1364-1367. doi: 10.1016/j.radcr.2019.08.009.
 

Møller T, James JP, Holmstrøm K, Sørensen FB, Lindebjerg J, Nielsen BS. Co-Detection of miR-21 and TNF-α mRNA in Budding Cancer Cells in Colorectal Cancer. Int J Mol Sci. 2019 20. pii: E1907. doi: 10.3390/ijms20081907.
 

Canto LMD, Cury SS, Barros-Filho MC, Kupper BEC, Begnami MDFS, Scapulatempo-Neto C, Carvalho RF, Marchi FA, Olsen DA, Madsen JS, Havelund BM, Aguiar S Jr, Rogatto SR. Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response. Sci Rep. 2019 9:8702. doi: 10.1038/s41598-019-45151-w.
 

Hansen TF, Carlsen AL, Tanassi JT, Larsen O, Sørensen FB, Jensen LH, Jakobsen A. MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy. Cancer Drug Resist. 2019 2: doi: 10.20517/cdr.2019.08
 

do Canto LM, Larsen SJ, Catin Kupper BE, Begnami MDFS, Scapulatempo-Neto C, Petersen AH, Aagaard MM, Baumbach J, Aguiar S Jr, Rogatto SR. Increased Levels of Genomic Instability and Mutations in Homologous Recombination Genes in Locally Advanced Rectal Carcinomas. Front Oncol. 2019 395. doi: 10.3389/fonc.2019.00395.
 

Traverso A, Kazmierski M, Shi Z, Kalendralis P, Welch M, Nissen HD, Jaffray D, Dekker A, Wee L. Stability of radiomic features of apparent diffusion coefficient (ADC) maps for locally advanced rectal cancer in response to image pre-processing. Phys Med. 2019 61:44-51. doi: 10.1016/j.ejmp.2019.04.009.
 

Freire PP, Fernandez-Garcia GJ, Moraes D, Cury SS, Pai-Silva MD, Reis PP, ROGATTO SR*, Carvalho RF*. The expression landscape of cachectic factors in human cancers. Journal of Cachexia, Sarcopenia and Muscle

Canto LM, Barros-Filho MC, Marinho D, Kupper BEC, Beganimi MDFS, Sacapulatempo-Netto C, Carvalho RF, Marchi FA, Baumbach J, Aguiar Jr S, ROGATTO SR. Methylation-based classifier of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal carcinomas. Scientific Reports 2019

 

Appelt AL, Andersen RF, Lindebjerg J, Jakobsen A. Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial. Am J Clin Oncol. 2019 doi: 10.1097/COC.0000000000000609.
 

Dizdarevic E, Frøstrup Hansen T, Pløen J, Henrik Jensen L, Lindebjerg J, Rafaelsen S, Jakobsen A, Appelt A. Long-term patient-reported outcomes after high-dose chemoradiotherapy for non-surgical management of distal rectal cancer. Int J Radiat Oncol Biol Phys. 2019 doi: 10.1016/j.ijrobp.2019.10.046.
 

Jensen LH, Olesen R, Petersen LN, Boysen AK, Andersen RF, Lindebjerg J, Nottelmann L, Thomsen CEB, Havelund BM, Jakobsen A, Hansen TF. NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer. Cancers (Basel). 2019 doi: 10.3390/cancers11111649
 

Dominguez-Valentin M, Seppälä TT, Sampson JR, Macrae F, Winship I, Evans DG, Scott RJ, Burn J, Möslein G, Bernstein I, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lindblom A, Plazzer JP, Tjandra D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Vidal JB, Rønlund K, Nielsen RT, Yilmaz M, Elvang LL, Katz L, Nielsen M, Ten Broeke SW, Nakken S, Hovig E, Sunde L, Kloor M, Knebel Doeberitz MV, Ahadova A, Lindor N, Steinke-Lange V, Holinski-Feder E, Mecklin JP, Møller P. Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report. Hered Cancer Clin Pract. 2019 17: 28. doi: 10.1186/s13053-019-0127-3. PMID: 31636762


2018


Jensen KH, Izarzugaza JMG, Juncker AS, Hansen RB, Hansen TF, Timshel P, Blondal T, Jensen TS, Rygaard-Hjalsted E, Mouritzen P, Thorsen M, Wernersson R, Nielsen HB, Jakobsen A, Brunak S, Sørensen FB. Analysis of a gene panel for targeted sequencing of colorectal cancer samples. Oncotarget. 2018 doi: 10.18632/oncotarget.24138.

 Thomsen CB, Hansen TF, Andersen RF, Lindebjerg J, Jensen LH, Jakobsen A. Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma. J Exp Clin Cancer Res. 2018 doi: 10.1186/s13046-018-0723-5.

 Eriksen AC, Andersen JB, Lindebjerg J, dePont Christensen R, Hansen TF, Kjær-Frifeldt S, Sørensen FB. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer? Diagn Pathol. 2018 doi: 10.1186/s13000-018-0697-9.

 Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, Hoeffel C, Kim SH, Laghi A, Maier A, Rafaelsen SR, Stoker J, Taylor SA, Torkzad MR, Blomqvist L. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018 28:1465-1475.

 Nederby L, Jakobsen A, Hokland M, Hansen TF. Quantification of NK cell activity using whole blood: Methodological aspects of a new test. J Immunol Methods. 2018 doi: 10.1016/j.jim.2018.04.002

 Christophides D, Appelt AL, Gusnanto A, Lilley J, Sebag-Montefiore D. Method for Automatic Selection of Parameters in Normal Tissue Complication Probability Modeling. Int J Radiat Oncol Biol Phys. 2018 doi: 10.1016/j.ijrobp.2018.02.152.

 Eriksen AC, Sørensen FB, Lindebjerg J, Hager H, dePont Christensen R, Kjær-Frifeldt S, Hansen TF. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study. Int J Colorectal Dis. 2018 doi: 10.1007/s00384-018-3076-9.

 Eriksen AC, Sørensen FB, Lindebjerg J, Hager H, dePont Christensen R, Kjær-Frifeldt S, Hansen TF. The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study. Transl Oncol. 2018: 979-987. doi: 10.1016/j.tranon.2018.03.008

 van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH; IWWD Consortium. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537-2545. doi: 10.1016/S0140-6736(18)31078-X.

 Knudsen KN, Lindebjerg J, Kalmár A, Molnár B, Sørensen FB, Hansen TF, Nielsen BS. miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy. Clin Exp Metastasis. 2018 doi: 10.1007/s10585-018-9945-3.

 Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, Daniels IR, Smart NJ, Osborne ME, Beets GL, Maas M, Bitterman DS, Du K, Gollins S, Sun Myint A, Smith FM, Saunders MP, Scott N, O'Dwyer ST, de Castro Araujo RO, Valadao M, Lopes A, Hsiao CW, Lai CL, Smith RK, Paulson EC, Appelt A, Jakobsen A, Wexner SD, Habr-Gama A, Sao Julião G, Perez R, Renehan AG. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018 doi: 10.1016/S2468-1253(18)30301-7.

 van Pelt GW, Kjær-Frifeldt S, van Krieken JHJM, Al Dieri R, Morreau H, Tollenaar RAEM, Sørensen FB, Mesker WE. Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations. Virchows Arch. 2018;473:405-412. doi: 10.1007/s00428-018-2408-z.

 Andersen IR, Olesen R, Boysen AK, Jensen LH, Mortensen FV, Nielsen DT, Rasmussen F. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib. Acta Radiol. 2018 doi: 10.1177/0284185118806652.

 Hansen TF, Kjær-Frifeldt S, Eriksen AC, Lindebjerg J, Jensen LH, Sørensen FB, Jakobsen A. Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts. Br J Cancer. 2018 doi: 10.1038/s41416-018-0285-5.

 Thomsen CB, Andersen RF, Lindebjerg J, Hansen TF, Jensen LH, Jakobsen A. Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment. Clin Colorectal Cancer. 2018 doi: 10.1016/j.clcc.2018.10.004.

 Hansen TF, Kjær-Frifeldt S, Lindebjerg J, Rafaelsen SR, Jensen LH, Jakobsen A, Sørensen FB. Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy. Acta Oncol. 2018 57: 528-533. doi: 10.1080/0284186X.2017.1385841. PMID: 28980848.


2017


Thomsen CEB, Appelt AL, Andersen RF, Lindebjerg J, Jensen LH, Jakobsen A. The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer. Cancer Med. 2017 6: 928-936. doi: 10.1002/cam4.1051. PMID: 28378527

 Bjerrum A, Andersen O, Fischer A, Lindebjerg J, Lynge E. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort. Int J Cancer. 2017 141: 503-511. doi: 10.1002/ijc.30756. PMID: 28463410

 Knudsen KN, Lindebjerg J, Nielsen BS, Hansen TF, Sørensen FB. MicroRNA-200b is downregulated in colon cancer budding cells. PLoS One. 2017 12:  doi: 10.1371/journal.pone.0178564. PMID: 28552992

 Dam C, Lindebjerg J, Jakobsen A, Jensen LH, Rahr H, Rafaelsen SR. Local staging of sigmoid colon cancer using MRI. Acta Radiol Open. 2017 6: 2058460117720957. doi: 10.1177/2058460117720957. PMID: 8804643

 Hansen TF, Andersen RF, Olsen DA, Sørensen FB, Jakobsen A. Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab. Sci Rep. 2017 7: 2388. doi: 10.1038/s41598-017-02538-x. PMID: 28539619

 Eriksen AHM, Sørensen FB, Andersen RF, Jakobsen A, Hansen TF. Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy. Oncol Lett. 2017 14: 201-209. doi: 10.3892/ol.2017.6141. PMID: 28693154

 Eriksen AC, Andersen JB, Kristensson M, dePont Christensen R, Hansen TF, Kjær-Frifeldt S, Sørensen FB. Computer-assisted stereology and automated image analysis for quantification of tumor infiltrating lymphocytes in colon cancer. Diagn Pathol. 2017 29: 65. doi: 10.1186/s13000-017-0653-0. PMID: 28851404

 Spindler KG, Boysen AK, Pallisgård N, Johansen JS, Tabernero J, Sørensen MM, Jensen BV, Hansen TF et al Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Oncologist. 2017 doi: 10.1634/theoncologist.2016-0178.
 Nottelmann L, Groenvold M, Vejlgaard TB, Petersen MA, Jensen LH. A parallel-group randomized clinical trial of individually tailored, multidisciplinary, palliative rehabilitation for patients with newly diagnosed advanced cancer: the Pal-Rehab study protocol. BMC Cancer. 2017 17: 560. doi: 10.1186/s12885-017-3558-0. PMID: 28835218

 Larsen MB, Mikkelsen EM, Rasmussen M, Friis-Hansen L, Ovesen AU, Rahr HB, Andersen B. Sociodemographic characteristics of nonparticipants in the Danish colorectal cancer screening program: a nationwide cross-sectional study. Clin Epidemiol. 2017 9: 345-354. doi: 10.2147/CLEP.S139168. PMID: 28721099


2016


Bjerrum A, Andersen O, Fischer A, Lindebjerg J, Lynge E. Colorectal cancer mortality 10 years after a single round of guaiac faecal occult blood test (gFOBT) screening: experiences from a Danish screening cohort. BMJ Open Gastroenterol. 2016 3: doi: 10.1136/bmjgast-2016-000120. PMID: 28074150

 Eriksen AH, Andersen RF, Pallisgaard N, Sørensen FB, Jakobsen A, Hansen TF. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer. PLoS One. 2016 11: e0150593. doi: 10.1371/journal.pone.0150593. PMID: 26937645

 Eriksen AH, Andersen RF, Nielsen BS, Sørensen FB, Appelt AL, Jakobsen A, Hansen TF. Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer. PLoS One. 2016 11: e0156919. doi: 10.1371/journal.pone.0156919. PMID: 27258547

 Pelt GW, Hansen TF et al. Stroma-High Lymph Node Involvement Predicts Poor Survival More Accurately for Patients with Stage III Colon Cancer. Journal of Medical & Surgical Pathology. 2016, 1: doi.org/10.4172/jmsp.1000116

 Andersen RF, Jakobsen A. Screening for circulating RAS/RAF mutations by multiplex digital PCR. Clin Chim Acta. 2016 458: 138-43. doi: 10.1016/j.cca.2016.05.007. PMID: 27181912

 Appelt AL, Sebag-Montefiore D. Technological advances in radiotherapy of rectal cancer: opportunities and challenges. Curr Opin Oncol. 2016 28: 353-8. doi: 10.1097/CCO.0000000000000306. PMID: 27153356 


 


Siden er sidst opdateret 04-10-2021.
Kontakt: admtda



Sygehus Lillebælt | Telefon 76 36 20 00 | Send sikker e-mail til Sygehus Lillebælt | Tilgængelighedserklæring